Safety and Efficacy Study of SUN-131 Transdermal System (TDS) as Compared to Placebo TDS in Patients With a Chalazion

NCT03248440 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

263

Enrollment

INDUSTRY

Sponsor class

Conditions

Chalazion

Interventions

DRUG: SUN-131 1.5% TDS
DRUG: Placebo TDS

Sponsor

Senju USA, Inc.